(D20) Benign neoplasm of soft tissue of retroperitoneum and peritoneum

More details coming soon

65 938 in individuals diagnosis benign neoplasm of soft tissue of retroperitoneum and peritoneum confirmed

1 347 deaths with diagnosis benign neoplasm of soft tissue of retroperitoneum and peritoneum

2% mortality rate associated with the disease benign neoplasm of soft tissue of retroperitoneum and peritoneum

Etiology Pathogenesis Clinical Pattern Diagnostics Treatment Prevention

Diagnosis benign neoplasm of soft tissue of retroperitoneum and peritoneum is diagnosed Women are 44.66% more likely than Men

18 245

Men receive the diagnosis benign neoplasm of soft tissue of retroperitoneum and peritoneum

668 (3.7 %)

Died from this diagnosis.

100

47 693

Women receive the diagnosis benign neoplasm of soft tissue of retroperitoneum and peritoneum

679 (1.4 %)

Died from this diagnosis.

Risk Group for the Disease benign neoplasm of soft tissue of retroperitoneum and peritoneum - Men aged 50-54 and Women aged 35-39

In Men diagnosis is most often set at age 0-1, 5-84

Less common in men the disease occurs at Age 0-5, 85-95+Less common in women the disease occurs at Age 90-95+

In Women diagnosis is most often set at age 0-89

Disease Features benign neoplasm of soft tissue of retroperitoneum and peritoneum

Absence or low individual and public risk

Benign neoplasm of soft tissue of retroperitoneum and peritoneum - what does this mean

Benign neoplasm of soft tissue of retroperitoneum and peritoneum is a condition that occurs when cells in the soft tissues of the retroperitoneum and peritoneum grow and divide abnormally, forming a mass of tissue called a tumor. these tumors are usually benign, meaning they are not cancerous. symptoms may include abdominal pain, bloating, and weight loss. treatment may involve surgery to remove the tumor and any affected tissue.

What happens during the disease - benign neoplasm of soft tissue of retroperitoneum and peritoneum

Benign neoplasm of soft tissue of retroperitoneum and peritoneum is caused by abnormal growth of cells in the soft tissue of the retroperitoneum and peritoneum. this growth is usually slow and is not caused by any infectious agent. it is often caused by genetic mutations or environmental factors, such as radiation or certain chemicals. the cells in the neoplasm may be benign, but can become malignant if left untreated.

Clinical Pattern

A benign neoplasm of soft tissue of retroperitoneum and peritoneum is a slow-growing, localized mass of abnormal cells that originate from the peritoneal and retroperitoneal tissue. It may present with abdominal pain, distension, and a palpable mass. It is usually discovered incidentally on imaging studies. Treatment typically involves surgical resection.

How does a doctor diagnose

Physical examination
Ultrasound
CT scan
MRI
Biopsy
Surgery
Chemotherapy
Radiation therapy

Treatment and Medical Assistance

Main goal of the treatment: To reduce the size of the benign neoplasm and to prevent its recurrence.

Surgery
Chemotherapy
Radiation therapy
Cryotherapy
Immunotherapy
Hormone therapy
Targeted therapy

11 Days of Hospitalization Required

Average Time for Outpatient Care Not Established

Benign neoplasm of soft tissue of retroperitoneum and peritoneum - Prevention

The best way to prevent benign neoplasms of soft tissue of retroperitoneum and peritoneum is to maintain a healthy lifestyle by eating a balanced diet, exercising regularly, and avoiding smoking and excessive alcohol consumption. additionally, regular check-ups with a healthcare provider can help identify any potential issues early on, allowing for timely treatment and prevention of further complications.

Diseases with similar symptoms